Skip to main content

Table 1 Sequences of primers used in this study

From: Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases

RAPSYN sense    5′- ACAATGCCATCAACCTTAGC −3′
RAPSYN antisense    5′- GTGAGTGAGGCAGGTTCATT-3′
RAPSYN probe 3′-BHQ-1 5′-JOE 5′- AGAATTATCTGACCCACCCATCCTGC-3′
β –GLOBIN sense    5′- CTAAGCCAGTGCCAGAAGAG-3′
β -GLOBIN antisense    5′- CTCTGCCCTGACTTTTATGC-3′
β GLOBIN probe 3′-BHQ-1 5′-FAM 5′- ACGGCTGTCATCACTTAGACCTCACC-3′